Multiple Sclerosis Flashcards

1
Q

What is multiple sclerosis (MS)?

A

Multiple sclerosis (MS) is defined as an inflammatory demyelinating disease characterised by the presence of episodic neurological dysfunction in at least two areas of the central nervous system (brain, spinal cord, and optic nerves) separated in time and space.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is the typical MS patient?

A

MS typically presents in young adults (under 50 years) and is more common in women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does pregnancy and the postpartum period affect MS?

A

Symptoms tend to improve in pregnancy and in the postpartum period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

At what age do most patients develop MS?

A

Most commonly diagnosed in people aged 20-40 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the different disease patterns of MS?

A
  • Clinically Isolated Syndrome
  • Relapsing-Remitting
  • Secondary progressive
  • Primary progressive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Briefly describe ‘Clinically Isolated Syndrome’

A

This describes the first episode of demyelination and neurological signs and symptoms. MS cannot be diagnosed on one episode as the lesions have not been “disseminated in time and space”. Patients with clinically isolated syndrome may never have another episode or develop MS. If lesions are seen on MRI scan then they are more likely to progress to MS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Briefly describe the ‘Relapsing-Remitting’ type of MS

A

Relapsing-remitting MS is the most common pattern at initial diagnosis. It is characterised by episodes of disease and neurological symptoms followed by recovery. In MS the symptoms occur in different areas with different episodes. This can be further classified based on whether the disease is active and/or worsening:

  • Active: new symptoms are developing or new lesions are appearing on MRI
  • Not active: no new symptoms or MRI lesions are developing
  • Worsening: there is an overall worsening of disability over time
  • Not worsening: there is no worsening of disability over time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Briefly describe the ‘Secondary Progressive’ type of MS

A

Secondary progressive MS is where there was relapsing-remitting disease at first, but now there is a progressive worsening of symptoms with incomplete remissions. Symptoms become more and more permanent. Secondary progressive MS can be further classified based on whether the disease is active and/or progressing.

  • Active: new symptoms are developing or new lesions are appearing on MRI
  • Not active: no new symptoms or MRI lesions are developing
  • Progressing: there is an overall worsening of disease over time (regardless of relapses)
  • Not progressing: there is no worsening of disease over time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Briefly describe the ‘Primary Progressive” type of MS

A

Primary progressive MS is where there is a worsening of disease and neurological symptoms from the point of diagnosis without initial relapses and remissions. This can be further classified in a similar way to secondary progressive based on whether it is active and/or progressing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Briefly describe the physiological structure of nerves and myelin

A

Myelin covers the axons of neurones in the central nervous system. This myelin helps the electrical impulse move faster along the axon. Myelin is provided by cells that wrap themselves around the axons. These are Schwann cells in the peripheral nervous system and oligodendrocytes in the central nervous system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Briefly describe the pathophysiology of MS

A

Multiple sclerosis typically only affects the central nervous system (the oligodendrocytes). There is inflammation around myelin and infiltration of immune cells that cause damage to the myelin. This affects the way electrical signals travel along the nerve leading to the symptoms of multiple sclerosis.

When a patient presents with symptoms of a clinical “attack” of MS, for example, an episode of optic neuritis, there are usually other lesions of demyelination at the same time throughout the central nervous system, most of which are not causing symptoms.

In early disease, re-myelination can occur and symptoms can resolve. In the later stages of the disease, re-myelination is incomplete and symptoms gradually become more permanent.

A characteristic feature of MS is that lesions vary in their location over time, meaning that different nerves are affected and symptoms change over time. The key expression to remember to describe the way MS lesions change location over time is that they are “disseminated in time and space”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which immune cells destroy myelin in MS?

A

CD4-mediated destruction of oligodendroglial cells and a humoral response to myelin binding protein are important pathological features.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What causes MS?

A

The cause of the demyelination is unclear, but there is growing evidence that it is influenced by a combination of:

  • Multiple genes
  • Epstein–Barr virus (EBV)
  • Low vitamin D
  • Smoking
  • Obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the risk factors of MS?

A
  • Female sex
  • Family history of MS
  • Northern latitude
  • Genetic factors
  • Smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical features of MS?

A
  • Visual disturbance in 1 eye
  • Peculiar sensory phenomena
  • Foot dragging or slapping
  • Leg cramping
  • Fatigue
  • Urinary frequency
  • Bowel dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How soon do symptoms appear in MS?

A

Symptoms usually progress over more than 24 hours. At the first presentation, symptoms tend to last days to weeks and then improve.

17
Q

What is the most common presentation of MS?

A

Optic neuritis.

18
Q

How does optic neuritis present?

A

Optic neuritis presents with unilateral reduced vision developing over hours to days.

It involves demyelination of the optic nerve and loss of vision in one eye.

Key features are:

  • Central scotoma
    • This is an enlarged blind spot
  • Pain on eye movement
  • Impaired colour vision
  • Relative afferent pupillary defect
19
Q

Briefly describe the managment and prognosis of a patient presenting with optic neuritis

A

Patients presenting with acute loss of vision should be seen urgently by an ophthalmologist for assessment.

It is treated with steroids and recovery takes 2-6 weeks.

Around 50% of patients with a single episode of optic neuritis will go on to develop MS over the next 15 years. Changes on an MRI scan help to predict which patients will go on to develop MS.

20
Q

MS is the most common cause of optic neuritis. What else can cause optic neuritis?

A
  • Sarcoidosis
  • Systemic lupus erythematosus
  • Diabetes
  • Syphilis
  • Measles
  • Mumps
  • Lyme disease
21
Q

How does optic neuritis present on fundoscopy?

A

In acute optic neuritis, the fundus appears normal because two thirds of cases of optic neuritis are retrobulbar. With time, the optic nerve may become pale. One third of patients with optic neuritis have a swollen disc (papillitis). The disc edema of optic neuritis often is diffuse

22
Q

What eye abnormalities are associated with MS?

A

Patients may present with double vision due to lesions with the sixth cranial nerve (abducens nerve).

There are two key phrases to remember to describe a sixth cranial nerve palsy:

  • Internuclear ophthalmoplegia
  • Conjugate lateral gaze disorder
23
Q

Briefly describe internuclear ophthalmoplegia

A

Unilateral lesions in the sixth nerve causes a condition called internuclear ophthalmoplegia. Internuclear refers to the nerve fibres that connect between the cranial nerve nuclei that control eye movements (3rd, 4th and 6th cranial nerve nuclei). The internuclear nerve fibres are responsible for coordinating the eye movements to ensure the eyes move together. Ophthalmoplegia means a problem with the muscles around the eye.

24
Q

Briefly describe conjugate lateral gaze disorder

A

Lesions in the sixth cranial nerve cause a conjugate lateral gaze disorder. Conjugate means connected. Lateral gaze is where both eyes move together to look laterally to the left or right. It is disordered in a sixth cranial nerve palsy. When looking laterally in the direction of the affected eye, the affected eye will not be able to abduct.

For example, in a lesion affecting the left eye, when looking to the left, the right eye will adduct (move towards the nose) and the left eye will remain in the middle as the muscle responsible for making it move laterally is not functioning.

25
Q

What focal weaknesses may be present in MS?

A

Focal weakness:

  • Bells palsy
  • Horners syndrome
  • Limb paralysis
  • Incontinence
26
Q

What focal sensory symptoms may be present in MS?

A

Focal sensory symptoms:

  • Trigeminal neuralgia
  • Numbness
  • Paraesthesia (pins and needles)
  • Lhermitte’s sign
27
Q

What is Lhermitte’s sign?

A

An electric shock sensation that travels down the spine and into the limbs when flexing the neck.

It indicates disease in the cervical spinal cord in the dorsal column. It is caused by stretching the demyelinated dorsal column.

28
Q

What is ataxia?

Briefly differentiate between sensory and cerebellar ataxia

A

Ataxia is a problem with coordinated movement. It can be sensory or cerebellar:

  • Sensory ataxia is the result of loss of the proprioceptive sense, which is the ability to sense the position of the joint (e.g. is the joint flexed or extended). This results in a positive Romberg’s test and can cause pseudoathetosis.
  • Cerebellar ataxia is the result of problems with the cerebellum coordinating movement. This suggestions cerebellar lesions.
29
Q

What investigations should be ordered for MS?

A
  • MRI brain
  • MRI spinal cord
  • Lumbar puncture
  • FBC
  • Comprehensive metabolic panel
  • Thyroid-stimulating hormone
  • Vitamin B12
30
Q

Briefly describe the diagnosis of MS

A

Diagnosis is made by a neurologist based on the clinical picture and symptoms suggesting lesions that change location over time. Symptoms have to be progressive over a period of 1 year to diagnose primary progressive MS. Other causes for the symptoms need to be excluded.

31
Q

Why investigate MS with MRI (brain and spinal cord)?

A

MRI scans can demonstrate typical lesions.

MRI brain shows hyperintensities in the periventricular white matter.

MRI spine shows demyelinating lesions in the spinal cord, particularly the cervical spinal cord.

32
Q

Why investigate using FBC, comprehensive metabolic panel, thyroid-stimulating hormone and vitamin B12?

A

All should be normal. Indicated to exclude alternative diagnoses or concomitant illness.

33
Q

Why investigate using lumbar puncture?

A

Lumbar puncture can detect “oligoclonal bands” in the cerebrospinal fluid (CSF).

34
Q

Briefly describe the approach in managing MS

A

Multiple sclerosis is managed by a specialist multidisciplinary team (MDT) including neurologists, specialist nurses, physiotherapy, occupational therapy and others. Patient should be fully educated about their condition and treatment.

35
Q

Briefly describe the use of ‘disease modifying’ drugs in treating MS

A

Treatment with disease-modifying drugs and biologic therapy has changed the management of multiple sclerosis so that the aim of treatment is now to induce long term remission with no evidence of disease activity.

There are many options that target various mechanisms such as interleukins, inflammatory cytokines and various immune cells.

36
Q

Briefly describe the treatment for relapses in MS

A

Relapses can be treated with steroids. NICE recommend methylprednisolone:

  • 500mg orally daily for 5 days
  • 1g intravenously daily for 3–5 days where oral treatment has failed previously or where relapses are severe
37
Q

Briefly describe the symptomatic treatment of MS

Note: exercise, neuropathic pain, depression, urge incontinence and spasticity

A

It is important to treat the symptom that result from the disease process along with treating the disease process itself:

  • Exercise to maintain activity and strength
  • Neuropathic pain can be managed with medication such as amitriptyline or gabapentin
  • Depression can be managed with antidepressants such as SSRIs
  • Urge incontinence can be managed with anticholinergic medications such as tolterodine or oxybutynin (although be aware these can cause or worsen cognitive impairment)
  • Spasticity can be managed with baclofen, gabapentin and physiotherapy
38
Q

What are the complciations of MS?

A
  • Urinary tract infection
  • Osteopenia and osteoporosis
  • Depression
  • Visual impairment
  • Erectile dysfunction (ED)
  • Cognitive impairment
  • Impaired mobility
39
Q

What differentials should be considered for MS?

A
  • Myelopathy due to cervical spondylosis
  • Fibromyalgia
  • Postural orthostatic tachycardia syndrome with or without cervicogenic migraine
  • Sleep disorders
  • Sjogren syndrome
  • Vitamin B12 deficiency
  • Peripheral neuropathy